Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    This FTSE 100 growth stock could be a better buy than AstraZeneca plc

    | Edward Sheldon, CFA

    AstraZeneca plc (LON: AZN) is a popular healthcare stock among UK investors. But is this FTSE 100 (INDEXFTSE:UKX) joint replacement…

    Read more »

    Investing Articles

    Why I’d buy this FTSE 250 stock alongside AstraZeneca plc

    | Kevin Godbold

    I think AstraZeneca plc (LON: AZN) pairs well with this FTSE 250 (INDEXFTSE: MCX) player.

    Read more »

    Investing Articles

    Why I see more upside ahead for AstraZeneca plc

    | Rupert Hargreaves

    I believe that AstraZeneca plc's (LON: AZN) growth is only just getting started and there's still plenty of potential for…

    Read more »

    Investing Articles

    Why I’d buy AstraZeneca plc for fat dividends and pipeline potential

    | Zach Coffell

    The expiry of blockbuster patents has led some to doubt AstraZeneca plc (LON: AZN), but one Fool believes the company…

    Read more »

    Investing Articles

    One growth stock I’d buy ahead of Astrazeneca plc

    | Paul Summers

    If dividends aren't a priority, Paul Summers think this top growth stock might be a better bet than Astrazeneca plc…

    Read more »

    Investing Articles

    AstraZeneca plc isn’t the only pharma star that could make you rich

    | Royston Wild

    AstraZeneca plc (LON: AZN) isn't the only pharma giant that could make you rich. Here Royston Wild looks at another…

    Read more »

    Investing Articles

    Why I’d ditch this defensive dividend stock to buy AstraZeneca plc

    | G A Chester

    G A Chester argues AstraZeneca plc (LON:AZN) is the pick of two defensive dividend stocks.

    Read more »

    Investing Articles

    This small-cap stock could be a better dividend buy than AstraZeneca plc

    | Jack Tang

    Dividend investing: should you buy AstraZeneca plc (LON:AZN) after a setback in its ‘Mystic’ clinical trial, or consider this small-cap…

    Read more »

    Investing Articles

    Why AstraZeneca plc could have a major impact on your investment performance

    | Peter Stephens

    AstraZeneca plc (LON: AZN) could be about to deliver vastly-improved financial performance.

    Read more »

    Investing Articles

    One super dividend stock I’d buy along with AstraZeneca plc

    | Kevin Godbold

    This firm’s impressive finances make it a serious potential pairing in my portfolio with AstraZeneca plc (LON: AZN).

    Read more »

    Investing Articles

    Why this dividend growth stock could be a better buy than AstraZeneca plc

    | Roland Head

    Roland Head explains why he's not buying AstraZeneca plc (LON:AZN) today.

    Read more »

    Investing Articles

    Why I’m not buying FTSE 100 giants AstraZeneca plc and Barclays plc for their dividends

    | Edward Sheldon, CFA

    Edward Sheldon looks at drugs giant AstraZeneca plc (LON: AZN) and banking behemoth Barclays plc (LON: BARC) and explains why…

    Read more »